Predictors of redetected chlamydia infection (n=12) after 11–22 months in 47 women who were chlamydia positive at baseline*
| Characteristic | Percentage of women with characteristic | Redetected infection with chlamydia % (proportion) of women | Relative risk (95% CI) | |
|---|---|---|---|---|
| With characteristic | Without characteristic | |||
| Age <20 years | 55.3 | 26.9 (7/26) | 23.8 (5/21) | 1.13 (0.42 to 3.05) |
| Smoking | 23.4 | 9.0 (1/11) | 30.6 (11/36) | 0.30 (0.04 to 2.06) |
| New partner during 12 months follow-up | 63.8 | 20.0 (6/30) | 35.3 (6/17) | 0.57 (0.22 to 1.48) |
| Bacterial vaginosis† | 32.6 | 26.7 (4/15) | 25.8 (8/31) | 1.03 (0.37 to 2.89) |
| Carcinogenic HPV† | 40.0 | 6.3 (1/16) | 41.7 (10/24) | 0.15 (0.02 to 1.06) |
*Of the 47 chlamydia positives at baseline, 17 were in the intervention group and 30 in the deferred screening control group. Of the 12 redetected cases of chlamydia infection at follow-up, three were in the intervention group and nine in the deferred screening control group.
†At baseline.